Davies J A, Menys V C
Br J Clin Pharmacol. 1983;15 Suppl 1(Suppl 1):45S-46S. doi: 10.1111/j.1365-2125.1983.tb02106.x.
1 Platelet monolayer adhesion to damaged rabbit aorta and to collagen-coated glass was quantified in a perfusion device. Addition of the thromboxane synthetase inhibitor dazoxiben (UK 37248) 1 and 10 microM reduced adhesion to damaged blood vessel by about 45% at both concentrations, but did not affect adhesion to collagen-coated glass. 2 Measurement by RIA indicated virtual abolition of thromboxane B2 production in the presence of the drug and a slight trend to an increase of 6-oxo-prostaglandin F1 alpha concentration in experiments using aorta. Inhibitory activity of dazoxiben was abolished by previous exposure of the aorta to 15-HPETE(?), an inhibitor of prostacyclin synthetase. 3 The results indicate that dazoxiben inhibits platelet adhesion to vascular subendothelium possibly by promoting synthesis of PGI2 from re-directed platelet endoperoxides.